Oligomeric Amyloid‐β, Tau Pathology, and Glucose Dysregulation in Alzheimer’s Disease: Uncovering Early Metabolic Vulnerability Associated with Soluble Aβ Species

Abstract

Background: Alzheimer’s disease (AD) is increasingly conceptualized as “Type 3 Diabetes” (T3D) due to its association with insulin resistance and glucose metabolic dysfunction.

The paper